{
    "clinical_study": {
        "@rank": "124308", 
        "arm_group": {
            "arm_group_label": "Ultrasonic Circular cyclocoagulation using HIFU", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The aim of the study is to evaluate the effectiveness and the safety of the cyclocoagulation\n      using HIFU in glaucoma patients"
        }, 
        "brief_title": "Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Glaucoma", 
        "condition_browse": {
            "mesh_term": "Glaucoma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Primary Open-angle glaucoma included pseudo-exfoliative glaucoma and pigmentary\n             glaucoma\n\n          -  IOP > 21 mm Hg on glaucoma medications, and indicated for filtering glaucoma surgery\n\n          -  Patient must be aged 18 years and more\n\n          -  No previous cyclophotocoagulation procedure in the eye\n\n          -  No previous laser treatment in the eye during the 3 months before HIFU procedure\n\n        Exclusion Criteria:\n\n          -  History of previous glaucoma surgery with implantation of glaucoma drainage device in\n             the study eye\n\n          -  History of ocular or retrobulbar tumor\n\n          -  retinal detachment, choroidal hemorrhage or detachment\n\n          -  Ocular infectious diseasee within 14 days before HIFU procedure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01791673", 
            "org_study_id": "EYEMUST-3"
        }, 
        "intervention": {
            "arm_group_label": "Ultrasonic Circular cyclocoagulation using HIFU", 
            "intervention_name": "Ultrasonic Circular Cyclocoagulation with EYEOP1 Device", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Glaucoma", 
            "Cyclocoagulation", 
            "HIFU - High Intensity Focused Ultrasound", 
            "Ciliary Body"
        ], 
        "lastchanged_date": "February 13, 2013", 
        "location": [
            {
                "contact": {
                    "email": "Alain.bron@chu-dijon.fr", 
                    "last_name": "Alain BRON, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France"
                    }, 
                    "name": "University Hospital"
                }, 
                "investigator": {
                    "last_name": "Alain BRON, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "faptel@chu-grenoble.fr", 
                    "last_name": "Florent APTEL, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France"
                    }, 
                    "name": "Michallon University Hospital"
                }, 
                "investigator": {
                    "last_name": "Florent APTEL, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jean-francois.rouland@chru-lille.fr", 
                    "last_name": "Jean-Fran\u00e7ois ROULAND, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France"
                    }, 
                    "name": "Huriez University Hospital"
                }, 
                "investigator": {
                    "last_name": "Jean-Fran\u00e7ois ROULAND, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "philippe.denis@chu-lyon.fr", 
                    "last_name": "Philippe DENIS, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France"
                    }, 
                    "name": "Croix Rousse University Hospital"
                }, 
                "investigator": {
                    "last_name": "Philippe DENIS, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pr_renard@yahoo.fr", 
                    "last_name": "Jean-Paul RENARD, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "HIA - Val de Grace Hospital"
                }, 
                "investigator": {
                    "last_name": "Jean-Paul RENARD, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Efficacy and Safety of Circular Cyclocoagulation Using High Intensity Focused Ultrasound With EYEOP1 Device in Glaucoma Patients. Prospective Multicenter Clinical Trial.", 
        "overall_official": {
            "affiliation": "Croix Rousse University Hospital", 
            "last_name": "Philippe DENIS, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Institutional Ethical Committee"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Success rate = complete success rate (achieved without ocular hypotensive medication) + qualified success (achieved with ocular hypotensive medication)", 
            "measure": "Success rate : Proportion of eyes that achieve an IOP of > 5 mmHg and <21 mmHg or an IOP reduction > 20%", 
            "safety_issue": "No", 
            "time_frame": "up to 12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01791673"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Average change in IOP (mm Hg)", 
                "safety_issue": "No", 
                "time_frame": "3, 6 and 12 months"
            }, 
            {
                "measure": "Percentage change in IOP from baseline", 
                "safety_issue": "No", 
                "time_frame": "3, 6 and 12 months"
            }, 
            {
                "measure": "Average change in glaucoma hypotensive medications", 
                "safety_issue": "No", 
                "time_frame": "3, 6 and 12 months"
            }, 
            {
                "measure": "Incidence of device and procedure-related complications during follow-up", 
                "safety_issue": "Yes", 
                "time_frame": "3, 6 and 12 months"
            }
        ], 
        "source": "EyeTechCare", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "EyeTechCare", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}